| |
| |
| Exchange: |
Nasdaq National Market |
| Security
Type: |
Common |
| Shares
Out: |
134,746,000 |
| Market
Cap: |
1.34(B) |
| Last
Volume: |
3,983,089 |
Avg
Vol: |
3,951,014 |
| 52
Week Range: |
$9.4 - $14.4 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Other |
|
Member Indexes:
|
| |
NASDAQ COMPOSITE |
|
NASDAQ NNM COMPOSITE |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : 754 |
| Guru Rank Value : 3 |
| Guru Occurances : 1 |
|
|
|
|
|
| |
|
Company Profile Dynavax Technologies is a commercial stage biopharmaceutical company engaged in developing and commercializing vaccines. Co.'s primary marketed product, Hepatitis B Vaccine (Recombinant), Adjuvanted (HEPLISAV-B), is approved in the U.S. and European Union for prevention of infection caused by known subtypes of hepatitis B virus in adults age 18 years and older. Co. also manufactures and sells CpG oligonucleotide (CpG) 1018 adjuvant, the vaccine adjuvant used in HEPLISAV-B. Co. developed CpG 1018 adjuvant to provide an increased vaccine immune response.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
46,784 |
46,784 |
1,774,313 |
| Total Sell Value |
$0 |
$661,866 |
$661,866 |
$25,545,876 |
| Total People Sold |
0 |
1 |
1 |
5 |
| Total Sell Transactions |
0 |
2 |
2 |
18 |
| End Date |
2025-03-30 |
2024-12-27 |
2024-06-28 |
2023-06-29 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Sun Elaine D |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,758 |
29,865 |
|
- |
|
| Macgregor Brent |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,758 |
21,829 |
|
- |
|
| Emini Emilio |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,439 |
10,075 |
|
- |
|
| Paradiso Peter R. |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,758 |
24,829 |
|
- |
|
| Silvernail Lauren P |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
1,439 |
10,075 |
|
- |
|
| Myers Scott Dunseth |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,758 |
31,204 |
|
- |
|
| Kisner Daniel L |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,758 |
23,329 |
|
- |
|
| Cano Francis |
Director |
– • – |
2025-06-11 |
4 |
A |
$0.00 |
$0 |
D/D |
5,758 |
42,663 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2025-03-18 |
4 |
AS |
$13.58 |
$190,392 |
D/D |
(14,020) |
8,078 |
|
-29% |
|
| Novack David F |
President & COO |
• – – |
2025-03-07 |
4 |
AS |
$14.39 |
$471,474 |
D/D |
(32,764) |
22,098 |
|
-31% |
|
| Slebir John L |
SVP General Counsel |
• – – |
2025-02-18 |
4 |
D |
$12.93 |
$69,279 |
D/D |
(5,358) |
36,373 |
|
- |
|
| Slebir John L |
SVP General Counsel |
• – – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
16,667 |
41,731 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2025-02-18 |
4 |
D |
$12.93 |
$52,250 |
D/D |
(4,041) |
77,485 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
11,904 |
81,526 |
|
- |
|
| Macdonald Kelly |
SVP and CFO |
• – – |
2025-02-18 |
4 |
D |
$12.93 |
$64,327 |
D/D |
(4,975) |
29,227 |
|
- |
|
| Macdonald Kelly |
SVP and CFO |
• – – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
15,477 |
34,202 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2025-02-18 |
4 |
D |
$12.93 |
$137,898 |
D/D |
(10,665) |
54,862 |
|
- |
|
| Novack David F |
President & COO |
• – – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
22,620 |
65,527 |
|
- |
|
| Spencer Ryan |
CEO and Director |
• • – |
2025-02-18 |
4 |
D |
$12.93 |
$472,307 |
D/D |
(36,528) |
260,733 |
|
- |
|
| Spencer Ryan |
CEO and Director |
• • – |
2025-02-18 |
4 |
OE |
$0.00 |
$0 |
D/D |
55,000 |
297,261 |
|
- |
|
| Slebir John L |
SVP General Counsel |
• – – |
2025-02-13 |
4 |
D |
$12.69 |
$59,745 |
D/D |
(4,708) |
25,064 |
|
- |
|
| Slebir John L |
SVP General Counsel |
• – – |
2025-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
14,000 |
28,397 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2025-02-13 |
4 |
D |
$12.69 |
$58,552 |
D/D |
(4,614) |
69,622 |
|
- |
|
| Janssen Robert |
SVP and CMO |
• – – |
2025-02-13 |
4 |
OE |
$0.00 |
$0 |
D/D |
13,000 |
74,236 |
|
- |
|
| Macdonald Kelly |
SVP and CFO |
• – – |
2025-02-13 |
4 |
D |
$12.69 |
$67,485 |
D/D |
(5,318) |
18,725 |
|
- |
|
326 Records found
|
|
Page 1 of 14 |
|
|
0.01 (0.1%) 
